PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Sanofi Consumer Healthcare India Limited

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Sanofi Consumer Healthcare India Limited's yearly results, compared with Healthcare companies in India. Tap ? on any ratio for what it means.

Where ₹100 of sales goes

₹66Operating costs₹0.2Interest₹27Net profit₹14Paid as dividends

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Data incomplete

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

—

Data incomplete

Growth Efficiency Ratio

—

Data incomplete

Asset Productivity Ratio

—

Data incomplete

Balance-sheet strength

Debt Due Cover Ratio

22.7×

Debt due within a year is covered 22.7 times by its yearly operating cash.

Higher than 84% of Healthcare companies in India.

Cash Cushion Ratio

+5%

Cash, after subtracting all debt, equals 5% of its market value (net cash).

Higher than 80% of Healthcare companies in India.

Tangible Assets Ratio

100%

Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 77% of Healthcare companies in India.

Tangible Net Worth Ratio

100%

Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 78% of Healthcare companies in India.

Shareholders

Shareholder Slice Ratio

—

Data incomplete

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Sanofi Consumer Healthcare India Limited owes ₹0.51 for every ₹1 it owns. Net profit rose 33% in the year to Dec 2025.

Compared with Healthcare companies in India · latest annual results Dec 2025.

P/E ratio

28.3

Investors pay ₹28.3 for every ₹1 of Sanofi Consumer Healthcare India Limited's yearly profit, lower than 68% of Healthcare companies in India.

P/B ratio

21.60

The share price is 21.60 times Sanofi Consumer Healthcare India Limited's book value per share, higher than almost all Healthcare companies in India.

Market cap

₹7,514 Cr

The total market value of all of Sanofi Consumer Healthcare India Limited's shares at today's price (share price × number of shares), larger than 58% of Healthcare companies in India. PosiCap size class: Mini Cap.

Net worth (book value)

₹348 Cr

What Sanofi Consumer Healthcare India Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

₹151.06

Net worth divided by the number of shares. The share price of ₹3,263 is 21.6 times this, which is the P/B above.

Return on equity (ROE)

88.0%

Sanofi Consumer Healthcare India Limited earned 88.0% on its shareholders' money over the last year, higher than almost all Healthcare companies in India.

Owes vs Owns

0.51×

Sanofi Consumer Healthcare India Limited owes ₹0.51 for every ₹1 it owns (moderate), higher than 86% of Healthcare companies in India.

Dividend yield

2.16%

Sanofi Consumer Healthcare India Limited pays 2.16% of its share price as dividends a year, higher than 95% of dividend-paying Healthcare companies in India.

Revenue growth

+23%

Revenue rose 23% in the year to Dec 2025.

Profit growth

+33%

Net profit rose 33% in the year to Dec 2025.

Profit margin

27.3%

Sanofi Consumer Healthcare India Limited keeps ₹27 of every ₹100 of revenue as net profit.

Cash quality

0.7×

Cash from Sanofi Consumer Healthcare India Limited's business was 0.7× its reported profit in the year to Dec 2025 — less cash came in than the profit reported.

Interest cover

141.6×

Sanofi Consumer Healthcare India Limited's operating profit covered its interest costs 141.6 times in the year to Dec 2025.

Cash vs debt

Net cash

Sanofi Consumer Healthcare India Limited held ₹350 Cr more cash than debt (net cash) at Dec 2025.

Questions

What is Sanofi Consumer Healthcare India Limited's P/E ratio?

Investors pay ₹28.3 for every ₹1 of Sanofi Consumer Healthcare India Limited's yearly profit, lower than 68% of Healthcare companies in India.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Sanofi Consumer Healthcare India Limited: ₹7,514 Cr ÷ ₹348 Cr (30 Jun 2026) = 21.6.

What is Sanofi Consumer Healthcare India Limited's return on equity?

Sanofi Consumer Healthcare India Limited earned 88.0% on its shareholders' money over the last year, higher than almost all Healthcare companies in India.

How much does Sanofi Consumer Healthcare India Limited owe compared with what it owns?

Sanofi Consumer Healthcare India Limited owes ₹0.51 for every ₹1 it owns (moderate), higher than 86% of Healthcare companies in India.

Does Sanofi Consumer Healthcare India Limited pay a dividend?

Yes. Sanofi Consumer Healthcare India Limited pays 2.16% of its share price as dividends a year, higher than 95% of dividend-paying Healthcare companies in India.

Is Sanofi Consumer Healthcare India Limited's revenue growing?

Revenue rose 23% in the year to Dec 2025.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.